Humoral and cellular immune response to second and third severe acute respiratory syndrome coronavirus 2 mRNA vaccine in patients with plasma cell dyscrasia.

Cancer medicine(2023)

引用 0|浏览8
暂无评分
摘要
This study highlighted the significance of booster SARS-CoV-2 mRNA vaccination in patients with PCD with respect to humoral and cellular immunity. Moreover, this study highlighted the potential impact of certain drug subclasses on vaccine-induced humoral immune response.
更多
查看译文
关键词
SARS-CoV-2,humoral and cellular immune response,mRNA vaccination,multiple myeloma,plasma cell dyscrasia
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要